Schedule 13G ownership disclosure

NOVOCURE LTD ORD SHS

Security class unavailable · CUSIP: G6674U108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,253,370
Percent of class
7.3200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-018541
Form type
SC 13G/A
Filer
NovoCure Ltd
CIK
CIK 1645113
Filed
Feb 12, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub